Clinical Trial Update: Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex [Phase 2]

View source ↗

Summary

Phase 2 study evaluating BIIB033 in participants with relapsing forms of multiple sclerosis when used concurrently with Avonex; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• BIIB033

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-05-03